The pharmaceutical sector in India showed positive movement on March 10, 2026, during early trading hours, with many stocks recording gains as of approximately 9:36 AM IST on BSE and 9:39 AM IST on NSE.
The S&P BSE HEALTHCARE Index stood at 43,830.1, reflecting a 1.0% increase. Over the past 30 days, the index gained 4.5%, and over the last year, it rose 10.4%. The benchmark S&P BSE SENSEX was at 77,798.02, up 0.3%.
Data from early trading on March 10, 2026, indicated upward price changes for several pharmaceutical stocks. Notable performers included:
- Corona Remedies Ltd.: BSE 1,675.00 (up 7.08%), NSE 1,668.60 (up 6.46%)
- Natco Pharma: BSE 1,047.40 (up 4.51%), NSE 1,043.10 (up 4.03%)
- Acutaas Chemicals: BSE 2,243.15 (up 4.12%), NSE 2,232.60 (up 3.62%)
- Granules India: BSE 578.00 (up 3.31%), NSE 577.80 (up 3.31%)
- Kwality Pharma: BSE 1,545.05 (up 3.49%) (not listed on NSE)
- Gufic Bioscience: BSE 287.05 (up 3.68%), NSE 285.20 (up 2.74%)
Other stocks with gains above 2% included Glenmark Pharma (BSE up 2.72%), Wockhardt (BSE up 2.72%), Anthem Biosciences Ltd. (BSE up 2.36%), Supriya Lifescience (BSE up 2.35%), and Lupin (BSE up 2.19%).
Some stocks showed minor declines or flat performance, such as Cipla (BSE down 0.09%), IPCA Labs (BSE down 0.06%), and Jubilant Industries (BSE down 4.08%).
Within the broader pharmaceuticals sector, top gainers mentioned included Aspira Pathlab & Diagnostics (up 15.8%) and Jagson Ph (up 11.7%), while losers included Choksi Lab. (down 8.5%) and Link Pharma (down 6.1%).